CIK 0001738021 · Non-accelerated filer<br>Smaller reporting company
Compass Therapeutics, Inc.
Sign in to watch- Ticker
- CMPX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-500-8099
- Business address
- 80 GUEST STREET, BOSTON, MA, 02135
- Former names
- Olivia Ventures, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 500,000 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 400,000 shares (grant or award)
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 20,000 shares at $4.05 ($81,000)
- 424B3 Offering Prospectus
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 20,000 shares at $4.19 ($83,800)
- EFFECT Other Notice of Effectiveness
- 8-K Event Other events
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 8-K Event Executive or director change
- 4 Open-market sale Chief Operating Officer sold 24,500 shares at an average $4.23 ($103,708)
- 4 Open-market sale Chief Operating Officer sold 22,261 shares at an average $4.36 ($96,986)
- SC 13D Stake Beneficial Ownership Report
- 3 Insider Initial Statement of Ownership
Page 10 of 19 · 362 filings